Jonathan C. Javitt - Jun 1, 2022 Form 4/A - Amendment Insider Report for NRX Pharmaceuticals, Inc. (NRXP)

Role
Chief Scientist, Director, 10%+ Owner
Signature
/s/ Jonathan C. Javitt
Stock symbol
NRXP
Transactions as of
Jun 1, 2022
Transactions value $
$58,000
Form type
4/A - Amendment
Date filed
6/2/2022, 09:46 AM
Date Of Original Report
Jun 2, 2022
Previous filing
Jun 10, 2021
Next filing
Dec 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NRXP Common Stock Purchase $58K +100K +215.83% $0.58 146K Jun 1, 2022 Direct
holding NRXP Common Stock 13.3M Jun 1, 2022 By Trust F1, F2
holding NRXP Common Stock 1.42M Jun 1, 2022 By Trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects charitable donations of 49,000 shares of Common Stock that occurred in December 2021.
F2 Held by the Jonathan Javitt Living Trust of which the Reporting Person is trustee.
F3 Held by The Javitt 2012 Irrevocable Dynasty Trust of which the Reporting Person is the Grantor.

Remarks:

The Form 4, as originally filed, incorrectly reported the price and is corrected herein.